Finance

Beta
Lists
041830:KOSDAQ
InBody Co Ltd
â‚©45,250.00
+9.43%
(+3,900.00) 1D
Jun 10, 3:15:06 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 041830...
Open
â‚©41,000
High
â‚©47,900
Low
â‚©41,000
Mkt. cap
611.36B
Avg. vol.
98.57K
Volume
204.04K
Dividend
1.33%
Quarterly dividend
â‚©150
Ex-dividend date
Mar 30, 2026
P/E ratio
14.56
52-wk high
â‚©48,900
52-wk low
â‚©22,850
EPS
â‚©3,107
Shares outstanding
13.48M
No. of employees
342
Open
â‚©41,000
High
â‚©47,900
Low
â‚©41,000
Mkt. cap
611.36B
Avg. vol.
98.57K
Volume
204.04K
Dividend
1.33%
Quarterly dividend
â‚©150
Ex-dividend date
Mar 30, 2026
P/E ratio
14.56
52-wk high
â‚©48,900
52-wk low
â‚©22,850
EPS
â‚©3,107
Shares outstanding
13.48M
No. of employees
342
News stories
From sources across the web
About InBody Co Ltd
CEOKichul Cha
Employees342
FoundedMay 15, 1996
Headquarters-
SectorMedical device
Websiteinbody.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
56.17B
59.80B
62.40B
68.44B
Cost of goods sold
11.25B
15.37B
13.65B
17.17B
Cost of revenue
11.25B
15.37B
13.65B
17.17B
Research and development expenses
2.29B
2.73B
3.31B
2.75B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
29.91B
29.33B
32.84B
33.01B
Operating expense
34.50B
34.62B
39.23B
38.25B
Total operating expenses
45.75B
49.99B
52.87B
55.42B
Operating income
10.42B
9.81B
9.52B
13.02B
Other non operating income
485.45M
17.43M
-186.36M
101.94M
EBT including unusual items
8.98B
11.77B
9.85B
17.93B
EBT excluding unusual items
9.00B
11.80B
9.94B
17.90B
Income tax expense
1.58B
2.37B
3.50B
1.63B
Effective tax rate
17.64%
20.17%
35.50%
9.10%
Other operating expenses
551.80M
668.50M
843.69M
638.94M
Net income
7.58B
9.64B
6.41B
16.33B
Net profit margin
13.49%
16.12%
10.28%
23.86%
Earnings per share
-
-
-
-
Interest and investment income
628.46M
743.09M
833.65M
905.44M
Interest expense
-85.25M
-145.77M
-176.26M
-103.59M
Net interest expenses
543.20M
597.31M
657.39M
801.84M
Depreciation and amortization charges
1.48B
1.44B
1.83B
1.65B
EBITDA
12.54B
11.87B
12.05B
15.33B
Gain or loss from assets sale
-11.71M
-5.13M
-30.63M
-25.26M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer